“Harnessing Immune Checkpoint Inhibitors Against Gastric Cancer: Charting the Course to Expanded Therapeutic Benefit”. 2024. Biomedical Research and Therapy 11 (4): 6305-25. https://doi.org/10.15419/bmrat.v11i4.877.